AUNDRIA CANNON: Open Payments
NPI 1942663885 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 45 payments from 12 companies in 2025. Trend: 2023 $1,229 · 2024 $558 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $279 |
| Exeltis, USA Inc. | 8 | $139 |
| Mayne Pharma Commercial LLC | 5 | $136 |
| Sumitomo Pharma America, Inc. | 5 | $105 |
| Sage Therapeutics, LLC | 3 | $63 |
| MILLICENT US INC | 4 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $19 |
Products named: Veozah, SLYND, ANNOVERA, MYFEMBREE, ZURZUVAE, FEMLYV, Mirena, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
